Literature DB >> 16575889

Behavioral and temperamental features of children with Costello syndrome.

Cédric Galéra1, Marie-Ange Delrue, Cyril Goizet, Kattalin Etchegoyhen, Emmanuelle Taupiac, Sabine Sigaudy, Benoît Arveiler, Nicole Philip, Manuel Bouvard, Didier Lacombe.   

Abstract

Costello syndrome (CS) is a rare genetic condition due to germline mutations in HRAS proto-oncogene and characterized by increased birth weight, postnatal growth retardation, distinctive facial appearance, typical medical problems (including feeding problems in the neonatal period), cutaneous anomalies, and developmental delay. Outgoing personality has often been noted in case reports, but few studies have focused specifically on the behavioral aspects of CS. A preliminary survey described irritability in younger patients with improvement between age 2 and 4, but a standardized psychometric tool was not used. A second study using the Child Behavior Checklist (CBCL) showed relatively high (albeit subclinical) levels of internalizing problems. These descriptive investigations lacked a control group. We describe a comparative survey to evaluate the behavioral and temperamental features of children with CS. We conducted a cross-sectional assessment using the CBCL and the Emotionality, Activity, Shyness, Sociability (EAS) temperament questionnaire to evaluate behavior and temperament in 11 CS children (2 years 5 months to 9 years) comparing them to 33 gender- and age-matched children without disability. The results suggest that the high levels of internalizing problems found before age 4 in CS patients might decrease with age. They also point to possible "hyperemotionality." Further studies using a larger sample size and IQ-matched control groups are needed to more accurately characterize individuals with this rare syndrome. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16575889     DOI: 10.1002/ajmg.a.31169

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

2.  Age-related differences in prevalence of autism spectrum disorder symptoms in children and adolescents with Costello syndrome.

Authors:  David D Schwartz; Jennifer M Katzenstein; Eric J Highley; Deborah L Stabley; Katia Sol-Church; Karen W Gripp; Marni E Axelrad
Journal:  Am J Med Genet A       Date:  2017-04-04       Impact factor: 2.802

3.  Socio-behavioral characteristics of children with Rubinstein-Taybi syndrome.

Authors:  Cédric Galéra; Emmanuelle Taupiac; Sonia Fraisse; Sophie Naudion; Eva Toussaint; Caroline Rooryck-Thambo; Marie-Ange Delrue; Benoit Arveiler; Didier Lacombe; Manuel-Pierre Bouvard
Journal:  J Autism Dev Disord       Date:  2009-04-07

4.  Autism traits in the RASopathies.

Authors:  Brigid Adviento; Iris L Corbin; Felicia Widjaja; Guillaume Desachy; Nicole Enrique; Tena Rosser; Susan Risi; Elysa J Marco; Robert L Hendren; Carrie E Bearden; Katherine A Rauen; Lauren A Weiss
Journal:  J Med Genet       Date:  2013-10-07       Impact factor: 6.318

5.  Longitudinal course of cognitive, adaptive, and behavioral characteristics in Costello syndrome.

Authors:  Marni E Axelrad; David D Schwartz; Julie E Fehlis; Elizabeth Hopkins; Deborah L Stabley; Katia Sol-Church; Karen W Gripp
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

6.  Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome.

Authors:  Yael Schonherz; Maayan Davidov; Ariel Knafo; Hadas Zilkha; Gal Shoval; Gil Zalsman; Amos Frisch; Abraham Weizman; Doron Gothelf
Journal:  J Neurodev Disord       Date:  2014-02-11       Impact factor: 4.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.